3-50341472-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015896.4(ZMYND10):c.1261A>C(p.Lys421Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,614,234 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. K421K) has been classified as Likely benign.
Frequency
Consequence
NM_015896.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZMYND10 | NM_015896.4 | c.1261A>C | p.Lys421Gln | missense_variant | Exon 12 of 12 | ENST00000231749.8 | NP_056980.2 | |
ZMYND10 | NM_001308379.2 | c.1246A>C | p.Lys416Gln | missense_variant | Exon 11 of 11 | NP_001295308.1 | ||
ZMYND10 | XM_005265216.4 | c.1024A>C | p.Lys342Gln | missense_variant | Exon 11 of 11 | XP_005265273.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152234Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251464Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135910
GnomAD4 exome AF: 0.0000424 AC: 62AN: 1461882Hom.: 0 Cov.: 31 AF XY: 0.0000454 AC XY: 33AN XY: 727242
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152352Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74498
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1261A>C (p.K421Q) alteration is located in exon 12 (coding exon 12) of the ZMYND10 gene. This alteration results from a A to C substitution at nucleotide position 1261, causing the lysine (K) at amino acid position 421 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at